IMpact of Mind-body Therapies (HYpnosis and Relaxation) on Anxiety in Children, Adolescents and Young Adults Who Had Been Treated in ONcology. Multicenter Study.
HARMONY-Impact
3 other identifiers
interventional
558
1 country
7
Brief Summary
In France today, it is estimated that one in 850 people aged between 20 and 45 has been cured of cancer in childhood. Some descriptive studies have established that cancer diagnosis and treatment can affect psychological health, with an increased risk of depression, post-traumatic stress, anxiety and suicidal risk. A French study published by our team in 2015 and 2020 also showed that, as adults, 40% of former pediatric cancer patients experienced symptoms of anxiety, a rate significantly higher than that of the general French population (25%). While it is well established that it is essential to detect the onset of anxiety-depressive disorders and, if necessary, to set up conventional psychological treatment (CPT), few studies have sought to show the benefit of complementing this conventional CPT with mind-body therapies (MBT) in the post-cancer pediatric setting. This project aims to determine the benefit of mind-body therapies (hypnosis and relaxation) as a complement to conventional psychological treatment (CPT) in the management of anxiety in children, adolescents and young adults in remission from pediatric cancer or leukemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedStudy Start
First participant enrolled
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
February 2, 2026
January 1, 2026
1.8 years
January 15, 2026
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on anxiety level in subjects aged 7 to 14 years old in remission from cancer or pediatric leukemia, compared to conventional psychological care alone.
Established according to the reference scale SCARED-51 (screen for child anxiety related disorders). On this scale, each item is rated from 0 (rarely) to 2 (often), assessing the intensity of the symptom over the previous 3 months. The total score, ranging from 0 to 102 for the SCARED-R-51, is calculated by adding up the scores for all items. The higher the score, the more severe the anxiety symptoms.
6 months after the first conventional psychotherapy session
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on anxiety level in subjects aged 15 to 25 years old in remission from cancer or pediatric leukemia, compared to conventional psychological care alone.
Established according to the Hospital Anxiety and Depression Scale (HADS). This scale comprises 14 items: 7 items relate to anxiety and 7 others to depression, allowing two separate scores to be obtained. Each response is rated from 0 to 3 on a scale that semi-quantitatively assesses the intensity of the symptom over the past week. The score for each part (anxiety/depression) is calculated by adding the values of the responses to the 7 corresponding items. Threshold scores for the two HAD subscales have been determined with the following values: 7 or less: no case, 8 to 10: doubtful case, and 11 and above: definite case.
6 months after the first conventional psychotherapy session
Secondary Outcomes (9)
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on anxiety level in subjects aged 7 to 14 years old in remission from cancer or pediatric leukemia, compared to conventional psychological care alone.
12 months after the first conventional psychotherapy session
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on anxiety level in subjects aged 15 to 25 years old in remission from cancer or pediatric leukemia, compared to conventional psychological care alone.
12 months after the first conventional psychotherapy session
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on the level of depression in subjects aged 7 to 14 years in remission from cancer or pediatric leukemia, compared to conventional psychological care alone
6 months then 12 months after the first conventional psychotherapy session
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on the level of depression in subjects aged 15 to 25 years in remission from cancer or pediatric leukemia, compared to conventional psychological care alone
6 months then 12 months after the first conventional psychotherapy session
Evaluate the benefits of mind-body therapy as a complement to conventional psychological care on the quality of life of subjects aged 7 to 25 in remission from pediatric cancer or leukemia, compared to conventional psychological care alone.
6 months then 12 months after the first conventional psychotherapy session
- +4 more secondary outcomes
Study Arms (2)
Standard psychological care
ACTIVE COMPARATORConventional follow-up. 9 sessions of standard psychological care to be completed within a maximum of 6 months (1 session every 2 weeks for 2 months, then 1 session per month for 4 months).
Standard psychological care + mind-body therapy
EXPERIMENTALStandard psychological care (conventional follow-up) + psychocorporal therapy over the same period, with the patient choosing between relaxation and hypnosis
Interventions
10 sessions to be completed within a maximum of 6 months (1 session every 2 weeks for 4 months, then 1 session per month for 2 months). Sessions conducted alternately or on the same day as conventional psychotherapy sessions.
9 sessions of standard psychological care to be completed within a maximum of 6 months (1 session every 2 weeks for 2 months, then 1 session per month for 4 months).
Eligibility Criteria
You may qualify if:
- HARMONY KIDS
- Patients receiving follow-up care after pediatric cancer at one of the participating centers,
- Patients with anxiety disorders (SCARED-R score ≥ 31)
- Patients affiliated with or eligible for social security,
- Patients and their parents (or legal guardians) who have received informed consent about the study and co-signed, with the investigator, a consent form to participate in the study.
- HARMONY AYA
- Patients receiving follow-up care after pediatric cancer at one of the participating centers,
- Patients with anxiety disorders (HADS-Anxiety score ≥ 8)
- Patients affiliated with or eligible for social security,
- For adult patients: patients who have received informed information about the study and have co-signed, with the investigator, a consent form to participate in the study,
- For minors: patients and their parents (or legal guardians) who have received informed consent about the study and have co-signed, with the investigator, a consent form for participation in the study.
You may not qualify if:
- HARMONY-Kids
- Patients suffering from severe depression (CDI score \> 40),
- Patients with suicidal thoughts regardless of their CDI score,
- Patients experiencing a cancer relapse,
- Refusal to participate,
- Pregnant women, women in labor, breastfeeding mothers,
- Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than research,
- Persons subject to legal protection measures (guardianship-curatorship) or unable to express their consent HARMONY-AYA
- Patients suffering from severe depression (HADS-Depression score \> 19)
- Patients with suicidal thoughts regardless of their HADS-Depression score,
- Patients with cancer relapse,
- Refusal to participate,
- Pregnant women, women in labor, breastfeeding mothers
- Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than research
- Adults subject to legal protection measures (guardianship-curatorship) or unable to give consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Centre Hospitalier Universitaire
Angers, 49933, France
Centre Hospitalier Universitaire Caen Normandie
Caen, 14033, France
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, 38043, France
Institut d'Hématologie et d'Oncologie Pédiatrique
Lyon, 69008, France
Centre Hospitalier Universitaire
Rouen, 76038, France
CENTRE HOSPITALIER UNIVERSITAIRE - site NORD
Saint-Etienne, 42055, France
CENTRE HOSPITALIER UNIVERSITAIRE - site HAUTEPIERRE
Strasbourg, 67200, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CLAIRE BERGER, MD
CHU DE SAINT-ETIENNE
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2026
First Posted
February 2, 2026
Study Start
March 2, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
February 2, 2026
Record last verified: 2026-01